1. Introduction {#sec0005}
===============

1.1. Recognition of non-self and innate immunity {#sec0010}
------------------------------------------------

The existence of a virus in a host requires a balance between replication of the virus and the antiviral defense of the host. The antiviral defense of the host is armed with a variety of immune surveillance mechanisms to eliminate invading viruses, and viruses in turn have evolved to subvert these barriers. Recognition of the invading virus is initiated by innate immunity mediated by an intricate system of pattern recognition receptors (PRRs) that specifically recognize pathogen-associated molecular patterns (PAMPs). The sensing of PAMPs initiates the induction of an appropriate immune response to virus infection. Toll-like receptors (TLRs) represent an essential family of PRRs, and several TLRs may be triggered by single-stranded RNA, double-stranded RNA, and a number of viral proteins activating signal transduction. Thus, TLR signaling is determined by the repertoire of PAMPs presented to TLRs by invading viruses (for reviews, see [@bib0015], [@bib0270]).

The events that occur following TLR recognition by invading viruses include induction of interferon regulatory factor 3 (IRF3) and nuclear factor-κB (NF-κB), which then switches on the expression of proinflammatory cytokines and chemokines that include interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)-α, RANTES, and type I interferons (IFN-α/β). Production of type I IFNs mediates antiviral host response through four main effector pathways; the Mx1 (myxovirus resistance 1) GTPase pathway, the dsRNA-dependent kinase PKR pathway, the 2′,5′-oligoadenylate synthetase-directed RNase L pathway, and the ISG15 (IFN-stimulated gene product of 15 kDa) uniquitin-like pathway (for review, see [@bib0260]). Cytotoxic T lymphocytes (CTLs) are also activated leading to a full range induction of viral-specific adaptive immune surveillance. The CTL activation is dependent especially on TLR3, -4, -7, and -9, and therefore the crosstalk between innate immunity and adaptive immunity is also triggered by TLRs.

TLRs are not the only family of PRRs that sense viral PAMPs. Retinoic acid-inducible gene I (RIG-I)-like RNA helicases (RLHs) also constitute an important family of PRRs that comprise RIG-I and melanoma differentiation-associated gene 5 (MDA-5) ([Fig. 1](#fig0005){ref-type="fig"} ) ([@bib0615]). RIG-I and MDA-5 are expressed in the cytosol where no TLR is expressed, and thus constitute an alternative defense mechanism, especially for RNA viruses that replicate exclusively in the cytoplasm. RLHs possess dsRNA unwinding helicase activity that is coupled to caspase activation and recruitment domains (CARDs) and that allow interaction with another CARD-containing protein, CARD adaptor inducing IFN-β (Cardif; also known as MAVS, IPS-1, or VISA), to stimulate activation of the antiviral transcription factors NF-κB and IRF3. A key difference between RIG-I and TLRs is that RIG-I functions mainly in fibroblasts, macrophages, and conventional dendritic cells, whereas in plasmacytoid dendritic cells (pDCs), RIG-I has no role and type I IFN production is solely dependent on TLRs 7/8 and 9.Fig. 1Production of type I interferon via RIG-I dependent pathway and IFN-mdediated JAK-STAT signalling pathway. For explanation, see the text (adopted from [@bib0005], [@bib0090], [@bib0525]).

NF-κB is another family of inducible transcription factors activated by TLRs and virus-induced RIG-I/MDA-5 pathways ([@bib0665]). The NF-κB transcriptional activators are comprised of five member proteins (RelA/p65, cRel, RelB, p100/p52, and p105/p50), and they share a structurally conserved Rel homology domain that contains a functional region responsible for dimerization and DNA binding. NF-κB proteins are sequestered in the cytoplasm as a complex with inhibitory IkB proteins that are activated by TLR ligands. Activating signals for NF-κB trigger phosphorylation of IkB by IkB kinase B (IKK-B), and phosphorylated IkB becomes ubiquitinated and degraded in the proteasome. As a consequence, NF-κB is released from IkB, and translocates to the nucleus to bind specific DNA sequences, which activates targeted gene expression (for a review, see [@bib0665]).

1.2. IFN production and signaling pathway {#sec0015}
-----------------------------------------

Among the various factors involved in type I IFN production, IRF3 plays a major role. IRF3 is constitutively expressed in most cell types and resides in the cytoplasm in its inactive form. When stimulated, IRF3 becomes phosphorylated and undergoes conformational changes, leading to dimerization and unveiling of the nuclear localization signal (NLS). Dimerized IRF3 translocates to the nucleus where it forms a complex with the transcription co-activator CREB (cAMP responsive element binding)-binding protein (CBP)/p300 ([@bib0350], [@bib0175]). The IRF3-CBP/p300 complex then binds to target DNA sequences, including the positive regulatory domain (PRD) I--III regions of the IFN-β promoter, and assembles basal transcription machinery and RNA polymerase II for IFN gene expression ([@bib0455]). Therefore, the transcriptional activity of IRF3 is entirely dependent on its association with CBP/p300 co-activators. Once IFN is expressed, it is secreted extracellularly and binds to IFN-aR (IFNAR) receptors on the plasma membrane of its own cells (autocrine) or neighbor cells (paracrine) ([Fig. 1](#fig0005){ref-type="fig"}) Immediately after IFNs bind to the IFNAR2 subunit, the IFNAR1 subunit is recruited to form the receptor--ligand complex. Janus kinase 1 (JAK1) and tyrosine kinase 2 (Tyk2) then trans-phosphorylate one another, resulting in phosphorylation of the cytoplasmic tails of receptors and recruitment of STAT (signal transducers and activator of transcription) proteins. STAT1 and STAT2 are tyrosine-phosphorylated and activated to form the STAT1/STAT2/IRF9 heterotrimeric complex designated interferon-stimulated gene factor 3 (ISGF3). STAT-bound ISGF3 then translocates to the nucleus where it binds to IFN-stimulated regulatory response elements (ISRE) in the promoter regions of IFN-α/β-regulated genes and upregulates their transcription. Thus, secreted IFN triggers the IFN-signaling cascade through the JAK-mediated STAT pathway and achieves transcriptional upregulation of IFN-stimulated genes (ISGs) ([@bib0005]).

1.3. Viral strategies for IFN evasion {#sec0020}
-------------------------------------

More than 300 ISGs have been identified so far and they are mostly related to innate immunity, thus specifying the antiviral state of the host. In turn, many viruses have evolved to evade the host immune system by expressing antagonistic proteins that interfere with host signaling pathways needed for expression of Type I IFN (reviewed in [@bib0615], [@bib0285], [@bib0465], [@bib0090], [@bib0525], [@bib0480], [@bib0140]). Some RNA viruses express proteins which function in the cytoplasm while other proteins are localized in the nucleus to intercept the antiviral defense despite the fact that RNA viruses generally replicate in the cytoplasm. Various strategies are employed for viral evasion from IFN and some examples are as follow.

### 1.3.1. Inhibition of biomolecular transports {#sec0025}

The poliovirus 3D protein, which localizes to the nucleus with 3C^pro^ in the form of precursor 3BCD, degrades the nuclear pore complex (NPC) structure, thereby blocking nucleo-cytoplasmic transport of host cell mRNA subsequent IFN induction (for a review, see [@bib0225]). The VSV (vesicular stomatitis virus) M protein targets another component of NPC and changes the nuclear transport channel ([@bib0185], [@bib0220]). The picornavirus proteases (poliovirus and FMDV \[foot and mouth disease virus\]) and pestivirus proteases (CSFV \[classical swine fever virus\] and BVDV \[bovine viral diarrhea virus\]) cause a shut-down of host cell metabolism to interfere with the IFN response ([@bib0060], [@bib0310], [@bib0520], [@bib0695]).

### 1.3.2. Inhibition of IRF3 activation {#sec0030}

The hepatitis C virus NS3-4A protease specifically cleaves IKK to inactivate IRF3 ([@bib0370]), and the P protein of rabies virus and G1 protein of Hantavirus prevent IRF3 phosphorylation ([@bib0095], [@bib0475]). IRF3 itself is degraded by the N^Pro^ protein CSFV and BVDV ([@bib0310], [@bib0040], [@bib0215]). Recently, the SARS coronavirus Nsp1 protein has been shown to regulate IRF3-dependent innate immunity for IFN production ([@bib0690], [@bib0155]). The NS1 protein of influenza A virus binds host RNA and then forms complexes with RIG-I that antagonize IFN induction ([@bib0410]). The V proteins of paramyxoviruses bind MDA-5 and inhibit the IFN promoter activation ([@bib0030]).

### 1.3.3. Inhibition of JAK-STAT pathway {#sec0035}

Paramyxovirus V protein is of particular interest as it participates in the JAK-STAT pathway ([@bib0780], [@bib0490], [@bib0495], [@bib0170], [@bib0450]). The SV5V protein induces STAT1 degradation while the paramyxovirus type 2 (PIV2) V protein induces STAT2 degradation, which in turn antagonizes IFN-α and -β signal transductions, or ISGF3 (interferon stimulated gene factor 3) function. As described above, IFN-α/-β induces an antiviral state in cells as an end point of signal transduction through the JAK-STAT pathway, and therefore evasion from IFNs by direct inhibition of STAT proteins is of a considerable benefit to the survival of the virus. The V protein-induced IFN antagonism is species-specific and is linked to successful host range determination for measles virus, Nipha virus, Hendra viruses, PIV2, and Newcastle disease virus (NDV) ([@bib0450], [@bib0490]; for a review, see [@bib0240]).

### 1.3.4. Modulation of NF-κB activity {#sec0040}

The role of NF-κB during viral infection is more complex than that of IRF3. Some viruses activate NF-κB to prevent the cells from apoptosis ([@bib0315]), and some viruses block NF-κB activity to delay the innate immune response until an infection is established.

2. PRRS and host response to PRRS {#sec0045}
=================================

Porcine reproductive and respiratory syndrome (PRRS) is an emerged and re-emerging disease in swine. PRRS was first recognized in 1987 in the U.S. and in Germany in 1990, independently ([@bib0275], [@bib0070]). PRRS quickly spread globally to most pig-producing countries and has become one of the most economically important diseases to the pork industry worldwide. Since its emergence, the virus has continued to evolve. A new type of PRRSV has been identified in the US ([@bib0500], [@bib0200]), and a highly virulent strain has appeared in China ([@bib0630], [@bib0660], [@bib0790]) and has spread to neighboring countries ([@bib0435], [@bib0205], [@bib0300]). Commercial vaccines are available against PRRS but their safety and efficacy are deemed unsatisfactory and the disease continues to plague the pork industry. A major obstacle in the development of a successful PRRS vaccine is an unconventional immune response of the pig to the virus. Infection of pigs with PRRSV instigates abundant production of antibodies in the infected animal ([@bib0340], [@bib0345]). However, the PRRSV antibodies are mostly non-neutralizing, and neutralizing antibody response is vague and weak with a delayed appearance ([@bib0395]). Infection of pig with PRRSV may lead to a poor lung defense and predisposes the pig to secondary bacterial infections that may increase clinical severity. Viremia eventually ceases but the pigs become persistently infected in the tonsils and lymphoid tissues for 6 months or longer ([@bib0035], [@bib0055], [@bib0715]) and may spread the virus to naïve animals, which may serve as an important means of transmission to susceptible herds ([@bib0710], [@bib0125], [@bib0025], [@bib0305], [@bib0085]).

The effects of cytokines on PRRSV have been extensively studied. A transient T cell response is detected at one month and lasts for two to three additional months post-infection ([@bib0065], [@bib0360]). During this period, cytokine response is mainly composed of IFN-γ secreted largely from CD4^+^ or CD8^+^ T cells ([@bib0160], [@bib0165], [@bib0390]) and to a lesser extent for IL-2 ([@bib0385], [@bib0390], [@bib0745]). TNF-α and IL-12 are also detectable in alveolar macrophages and dendritic cells, and the IL-10 response is unusually strong and high. During PRRSV infection, IL-10 expression increases in PBMC and also in the bronchoalveolar lavage fluids in infected pigs ([@bib0010], [@bib0595], [@bib0600]). IL-10 levels seem to inversely correlate with IFN-γ response, indicating an involvement of T-cell, IL-10, and IFN-γ responses against PRRSV. PRRSV seems to be highly susceptible to both IFN-α and -β ([@bib0020], [@bib0445]), but PRRSV-affected pigs do not elicit adequate induction of IFNs. IFN-α is not detected in the lungs of pigs where PRRSV is actively replicating. Both IFN-α and INF-β production are low and clearly down-regulated in pulmonary alveolar macrophages (PAMs) and in PRRSV-permissive monkey kidney cells (MARC-145) ([@bib0020], [@bib0100], [@bib0675], [@bib0515]). Accumulating data suggests that PRRSV may inhibit IFN-α response ([@bib0335], [@bib0405]), and that this inhibition is RIG-I mediated ([@bib0365]). Such inadequate innate responses may result in the delayed clearance and persistence of virus. Impairment of IFN-α production by PRRSV would also affect the development of an effective T helper type 1 (Th1) response and lead to a weakly induced cellular response and viral persistence in infected pigs, which would be of significant benefit to the virus. Viral persistence is generally related to the ability of the virus to evade host antiviral defense combined with a viral capacity to establish persistent infection within cells. Virus-infected animals activate both innate and adaptive immune responses, and when antiviral defense is unsuccessful, viruses may still persist. Different PRRSV isolates appear to have different abilities to induce or inhibit IFN-α ([@bib0335]), and this difference may be attributed to the genetic diversity of the virus. The mechanism for virulence and persistence of PRRSV is yet unclear, and the molecular basis for IFN suppression by PRRSV has not been studied until recently. It is postulated that at least one of the mechanisms for viral persistence may be related to the modulation of type I IFN production by PRRSV. This series of interactive processes between virus and cell trigger differential expression of cellular genes, which has been of interest in understanding how altered gene expression plays a role during PRRSV infection. PRRSV seems to possess an ability to disarm the host antiviral defense. As a consequence, the virus readily survives in the pig without being eliminated and is spread to naïve animals. Counter-acting the ability of PRRSV to disarm the host defense would be the key to controlling PRRSV infection and blocking transmission.

3. PRRSV proteins and their role in host response modulation {#sec0050}
============================================================

PRRSV is a porcine arterivirus belonging to the family *Arteriviridae* in the order *Nidovirales* ([http://www.ictvonline.org/virusTaxonomy.asp?version=2009](http://www.ictvonline.org/virusTaxonomy.asp%3Fversion=2009)). PRRSVs in North America and Europe share only 55--80% of sequence identity in different viral genes and form two distinct genotypes (for a review, see [@bib0425]). The viral genome is a positive-sense RNA of 15 kb in size and contains 9 ORFs; ORF1a, ORF1b, ORF2a, ORF2b, and ORF3 through ORF7. The viral genome is translated to produce two polyproteins from ORF1a and ORF1b, and ORF1a alone can produce PP1a of 2503 amino acids. ORF1b does not contain an initiating codon and therefore is expressed as PP1a/1b in the form of a fusion protein of 3960 amino acids with PP1a by ribosomal frame-shifting ([@bib0145], [@bib0735]). PP1a and PP1a/1b are co-translationally processed to 14 proteolytic cleavage products. These proteins are only found in PRRSV-infected cells and thus are non-structural proteins (Nsps) designated Nsp1 through Nsp12 in order from the N-terminus ([@bib0670], [@bib0540], [@bib0545], [@bib0550], [@bib0555], [@bib0685]). Nsp1 and Nsp7 are both internally cleaved and produce Nsp1α and Nsp1β, and Nsp7α and Nsp7β, respectively. Similar to those of coronaviruses and equine arteritis virus (EAV), PRRSV Nsp\'s function in genome replication and mRNA synthesis. PP1a contains three protease motifs: papain-like cysteine protease (PCP) in Nsp1, poliovirus 3C-like cysteine protease (CP) in Nsp2, and serine protease (SP) in Nsp4. The polyprotein processing for PRRSV is similar to that of EAV such that PCP generates Nsp1α and Nsp1β, CP cleaves off Nsp2, and SP generates Nsp3 through Nsp12.

PRRSV structural proteins are encoded in the 3′-most 3 kb of the viral genome. This region contains ORF2a, ORF2b, and ORF3 through ORF7 and codes for seven structural proteins: glycoprotein 2 (GP2), small envelope (E), GP3, GP4, GP5, membrane (M), and nucleocapsid (N) proteins, respectively ([@bib0400], [@bib0735]). The E protein is a small, hydrophobic, myristoylated membrane protein of 73 amino acids ([@bib0180]). E is likely an ion-channel protein of the virus involved in the uncoating process during virus entry ([@bib0325]). GP5 and M form a heterodimer with unknown function. GP2, GP3, and GP4 are minor components of the virion and form a heterotrimer ([@bib0700]) that may function as a viral ligand that recognizes CD163 as the cellular receptor to initiate infection ([@bib0135]). N protein binds to viral genomic RNA and constitutes the viral capsid.

3.1. Nuclear-cytoplasmic proteins of PRRSV {#sec0055}
------------------------------------------

As with many other RNA viruses, the entire life cycle of PRRSV occurs in the cytoplasm of infected cells, and thus viral-specific proteins are predominantly localized in the cytoplasm of infected cells, especially in the perinuclear region, endoplasmic reticulum (ER) and Golgi, and internal membranes. An unusual feature of PRRSV is that the viral N protein localizes to the nucleus and nucleolus in addition to its normal cytoplasmic distribution ([@bib0505]). Since the N protein is a major structural component essential for viral assembly, and because PRRSV assembly and maturation takes place in the ER and Golgi of the cell, the N protein has been postulated to play dual roles - a structural role in the cytoplasm and a non-structural role in the nucleus. Recently, the nonstructural protein Nsp1 has been identified as an additional nuclear protein of PRRSV ([@bib0770]; [Fig. 3](#fig0015){ref-type="fig"} ). Nsp1 is the first viral protein synthesized during infection, and both N and Nsp1 appear to modulate normal host cell process and immune surveillance.Fig. 3Nuclear cytoplasmic distribution of N, Nsp1, and Nsp1α subunit of Nsp1. HeLa cells were gene-transfected and stained at 24 h with N-specific monoclonal antibody SDOW17 (top panel), or with anti-FLAG antibody for Nsp1 (middle panel) and Nsp1α proteins (bottom panel). Nuclear distribution is indicated by white or black arrows. The N protein in particular is distributed in the nucleolus (yellow arrows), in addition to the nucleus and cytoplasm.

### 3.1.1. Nucleocapsid (N) protein {#sec0060}

The N protein is a small basic protein of 123 amino acids. As for many other RNA viruses, N is the most abundant virion component and the most immunogenic protein in PRRSV-infected pigs. The PRRSV N protein is a serine-phosphoprotein with unknown function ([@bib0730]). As the sole protein component of the viral capsid, N associates with itself by both covalent and non-covalent interactions, providing the basis for viral capsid assembly. The covalently-linked N-N homodimerization is formed in the lumen of the ER and the Golgi complex through disulfide linkages via a cysteine residue at position 23 ([@bib0725]). Cysteine 23 of N is essential for virus replication and infectivity, indicating the importance of N-N dimerization for virion assembly ([@bib0315]).

#### 3.1.1.1. Nuclear localization of N and interaction with fibrillarin {#sec0065}

Since N protein nuclear localization has been reported for PRRSV, N proteins of EAV ([@bib0650]), lactate dehydrogenase elevating virus of mouse (LDV; [@bib0420]), simian hemorrhagic fever virus (SHFV; [@bib0415]), and coronaviruses including avian infectious bronchitis virus, transmissible gastroenteritis virus, and murine hepatitis virus ([@bib0235], [@bib0740]) have been studied for nuclear localization which seems to be a common feature in nidoviruses. A functional motif for the nuclear localization signal (NLS) in PRRSV N is ~41~PGKKNKK which interacts with the nuclear transporters importin-α and importin-β ([@bib0510]). Therefore, the N protein seems to localize in the nucleus through the NLS-dependent and importin α/β-mediated nuclear transport pathway. Once in the nucleus, the N protein co-localizes and specifically interacts with a set of cellular proteins. Cellular proteins that have been identified as interacting partners of N include fibrillarin ([@bib0765]), I-mfa domain containing protein (HIC) ([@bib0565]), protein inhibitor of activated STAT1 (PIAS1), and other proteins including nucleolin, B23, poly-A binding protein ([@bib0560]), importin-α and -β, and exportin ([@bib0510]). The nuclear import of N protein is faster than its nuclear export, and thus the N protein is apparently localized in greater amounts in the nucleolus ([@bib0775]).

The nucleolus, where PRRSV N localizes, is a subcellular structure involved in cellular processes such as ribosomal RNA synthesis, modulation of cell growth, and response to cell stress ([@bib0530]). Fibrillarin is a major cellular protein in the nucleolus, and thus was the first protein studied for its interaction with PRRSV N. Fibrillarin is a component of the small nucleolar ribonucleoprotein (snoRNP) complex that participates in the precursor ribosomal RNA processing and cell cycle progression ([@bib0485]). The fibrillarin and N protein complex appears to be restricted to the dense fibrillar component and nearby regions of the nucleolus and associated with box C/D snoRNAs to form snoRNP complexes ([@bib0765]). The small nucleolar RNAs contain an antisense element complementary to rRNAs, and the antisense snoRNAs function as the guide for snoRNPs in the dense fibrillar component. The snoRNPs then participate in the site-specific 2′-O-ribose methylation of the pre-rRNA and the precise pre-rRNA cleavage processing for assembly of ribosomal subunits ([@bib0655]). Since both fibrillarin and N protein function as RNA binding proteins, co-localization to the same site may reflect a common RNA binding function, and in fact, the N protein and fibrillarin interaction requires RNA. Since replication of PRRSV genomic RNA is restricted to the cytoplasm and because fibrillarin exists mainly in the nucleus and nucleolus, it is likely that precursor rRNA, which is abundantly present in the dense fibrillar component where the N and fibrillarin co-localization is detected, may be the RNA species participating in this interaction in the nucleolus. Indeed, the PRRSV N protein has been shown to be able to bind to both 28S and 18S rRNAs ([@bib0765]). Therefore, it is possible that N and fibrillarin may compete for the same rRNA substrate in the dense fibrillar component of the nucleolus, which may result in the modification of fibrillarin function in virus-infected cells. Alternatively, the binding of nucleolar RNAs in the fibrillar region may direct a conformational change of N sufficient to facilitate a stable interaction with other nucleolar proteins, such as fibrillarin, and subsequently allow the N protein to counter-regulate the fibrillarin function such as site-specific methylation, leading to uncontrolled cleavages of pre-rRNA. This hypothesis is supported by the observation that the co-localization of N and fibrillarin does not occur in the Cajal body ([@bib0765]), where unlike the nucleolus, rRNA is absent. Additional supporting evidence includes the cleavage of 28S rRNA in PRRSV-infected MARC-145 cells (unpublished data). These studies implicate the involvement of N in the ribosome biogenesis and cell cycle progression. Hijacking the nucleolar function and cell cycle arrest are considerable benefits to the virus since the available pool of cellular machineries can be maximally utilized towards the production of progeny virus at the early stage of infection.

#### 3.1.1.2. Interaction of N with HIC {#sec0070}

Using N as bait in yeast-2 hybrid screening, an additional cellular protein interacting with N has been identified, I-mfa (inhibitor of MyoD family) domain-containing protein (HIC) ([@bib0565]). HIC is a transcription factor that has been identified as a binding partner of CD4 in humans ([@bib0625]), and it differentially regulates transcriptional activities of human immunodeficiency virus (HIV) and human T-cell leukemia virus (HTLV) long terminal repeats (LTR). I-mfa is a myogenic repressor protein and is an inhibitor of MyoD family ([@bib0105]). MyoD is a family of transcription factors regulating somitogenesis. I-mfa inhibits MyoD-mediated muscle differentiation ([@bib0290]). The physical interaction between the cysteine-rich domain at the C-terminus of I-mfa and the myogenic basic helix--loop--helix protein contribute to the inhibitory effect of I-mfa. The porcine HIC contains a cysteine-rich domain analogous to that of I-mfa and contains a sequence that resembles a nucleolar localization signal. HIC is a zinc-binding protein, and confocal microscopy shows co-localization of PRRSV N with the HIC-p40 isomer in the nucleus and nucleolus, and in the cytoplasm with the HIC-p32 isomer, which is an N-terminal truncation of HIC-p40. Porcine HIC is universally expressed in tissues of pig including alveolar macrophages. The interaction of viral capsid protein with the cellular transcription factor implicates a possible regulation of host cell gene expression by N during PRRSV infection. The I-mfa signature domain is found in porcine HIC. The N protein binds HIC-p32 effectively, and co-expression of N with HIC-p32 or HIC-p40 does not change their subcellular distributions, suggesting that N binding to HIC likely results in the functional modification of HIC in association with the I-mfa signature domain. Although the biological function of HIC is largely unknown, recent studies show that HIC interacts with cyclin T1 in cells and stimulates positive transcription elongation factor (P-TEFb)-dependent transcription. Cyclin T1 is a component of the P-TEFb complex, which is known to participate in the control of cell cycle progression. Since PRRSV N protein can undergo physical interaction with fibrillarin and co-localizes with fibrillarin in the nucleolus ([@bib0765]), it is possible that the N-HIC interaction in conjunction with N-fibrillarin interaction participates in the regulation of cell cycle progression. During the expression of N, cells accumulate at the G2/M phase ([@bib0415]), indicating that the N protein is responsible for delay of cell cycle progression. The arrest of cell cycle progression is beneficial for the virus to subvert host cell function and increases the efficiency of virus production ([@bib0230], [@bib0190]).

#### 3.1.1.3. Upregulation of IL-10 by N {#sec0075}

Accumulating evidence shows that PRRSV strongly induces interleukin (IL)-10 production in pigs during an early phase of infection ([@bib0595], [@bib0600], [@bib0620]). IL-10 induction has been observed in both North American and European types of PRRSV. IL-10 is a potent cytokine that functions to suppress innate and adaptive immune responses. Because protection against viral infection relies on the induction of viral-specific cell-mediated immunity, interference and delay of the crosstalk between antigen presenting cells and T cells are significant benefits for the virus to survive in the host. The induction of IL-10 and other inhibitory factors by PRRSV is mediated by interaction between PRRSV proteins and macrophages/dendritic cells as these cells are susceptible targets for PRRSV infection and play important roles in the induction of anti-viral innate and adaptive immunity. We have sought to identify a viral protein responsible for IL-10 induction using individual PRRSV genes, and have recently obtained convincing evidence that the N protein plays a significant role (unpublished data). The PRRSV N protein induces IL-10 production in peripheral blood mononuclear cells (PBMCs) of pig and in cultivated PAMs as the primary target cells of PRRSV ([@bib0720]). The expression of PRRSV N results in significant induction of IL-10 expression in PAMs. PRRSV N stimulated IL-10 production is similar to the observation for human hepatitis C virus infection ([@bib0050]). For HCV, the core protein is linked to the increase of IL10 production in PBMCs. A study is in progress in my laboratory to elicit the mechanism of IL-10 induction by PRRSV N.

#### 3.1.1.4. In vivo role of N in PRRSV-infected pigs {#sec0080}

The in vivo role of N protein nuclear localization in pigs has been examined using an NLS-null mutant PRRSV ([@bib0320], [@bib0460]). Two lysine residues at the NLS motif of ~41~PGKKNKK were substituted to glycine, and the modified NLS to ~41~PGGGNKK restricted the N protein to the cytoplasm. Then using an infectious cDNA clone, the NLS-null mutation was introduced into the viral genome, and an NLS-null mutant virus was rescued, showing that the nuclear localization of N is not essential for PRRSV infectivity. When the host response to the NLS-null virus was examined in the piglet model, NLS-null virus-infected pigs showed milder clinical signs with a significantly shorter mean duration of viremia compared to wild-type PRRSV-infected pigs, and developed higher titers of neutralizing antibodies. Mutations occurred at the NLS locus in one pig during viremia, and both wild-type and NLS-null viruses persisted in the tonsils. The NLS-null virus persisting in the tonsils was found to be mutated in the NLS locus. No other mutation was found in the N gene. All types of reversions that occurred during viremia and persistence were able to translocate the mutated N proteins to the nucleus, indicating strong selection pressure for reversion at the NLS locus of the N protein in vivo. Reversions from NLS-null to functional NLS in the tonsils suggest a possible correlation of viral persistence with N protein nuclear localization. To prevent the reversion to functional NLS, a series of small deletions were additionally made in NLS of N, and the resulting mutant viruses were tested in pigs ([@bib0460]). Similar results were obtained. These studies show that N protein nuclear localization is non-essential for PRRSV multiplication but does play an important role in viral attenuation and in pathogenesis in pigs.

### 3.1.2. Nsp1 as a modulator for IFN response {#sec0085}

#### 3.1.2.1. Processing and structure of Nsp1 {#sec0090}

Nsp1 is the first viral protein synthesized during PRRSV infection. Unlike EAV Nsp1 that has a single proteinase motif, two proteinase motifs are found for PRRSV Nsp1. PRRSV Nsp1 is a 382-amino acid protein and contains two papain-like cysteine proteinase (PCP) domains, designated PCPα and PCPβ. Active sites for PCPα and PCPβ have been mapped to C76-H146 and C271-H340, respectively ([@bib0150]). The protease activity of PCPα is responsible for generation of Nsp1α, whereas the PCPβ activity generates Nsp1β by cleaving Y382-A383 from the nascent polypeptide chain of the PP1a. After cleavage of Nsp1β from Nsp2, no trans-cleavage protease activity is observed for Nsp1α and Nsp1β and therefore the enzymatic activity of PCPα and PCPβ seems to be no longer functional, which is probably due to conformational changes after cleavage. The PCPα activity is required for subgenomic mRNA synthesis but is not involved in genomic RNA replication ([@bib0295]). The internal cleavage of Nsp1 to generate Nsp1α and Nsp1β was initially predicted to occur at Q166-R167, and this prediction had long been the structural basis for two subunits: 166 amino acids for Nsp1α and 216 amino acids for Nsp1β ([@bib0150]). A zinc finger motif (ZF1) of C8--C10--C25--C28 is found at the N-terminal region of Nsp1α, and this motif along with PCPα activity is required for transactivation of subgenomic RNA synthesis ([@bib0640], [@bib0645], [@bib0635]). Recently, an X-ray crystallographic study was conducted for Nsp1α and mapped the precise internal cleavage site to M180/A181, yielding Nsp1α subunit of 180 amino acids and Nsp1β subunit of 202 amino acids ([@bib0585]) ([Fig. 2](#fig0010){ref-type="fig"}B). In parallel with the crystallographic study, [@bib0110] has also determined by peptide sequencing the precise internal cleavage site of Nsp1 to M180/A181. These findings overturn the previous prediction for Nsp1 cleavage and show that the naturally cleaved authentic Nsp1α subunit is 14 amino acids extended at the C-terminus, and therefore Nsp1β is 14 amino acids shorter at its N-terminus when compared to the previous prediction. Most importantly, the presence of a second zinc-finger (ZF2) configuration of C70--C76--H146--M180 has been identified in the C-terminal half of Nsp1α and shown to hold an additional Zn^++^ ion in addition to the ZF1 motif in the N-terminal region. The ZF2 configuration includes M180 which is the terminal residue of Nsp1α, suggesting that Nsp1α may contain a previously unidentified biological function that may be associated with the ZF2 structure.Fig. 2Processing of PRRSV Nsp1 protein and primary structure of Nsp1α and Nsp1β subunits of Nsp1. Numbers indicate amino acid positions. ZF1 represents the zinc-finger motif composed of C8--C10--C25--C28 in the N-terminal region, and ZF2 represents the second zinc-finger motif of C70--C76--C146--C180 in the C-terminal region of Nsp1α identified by X-ray cystallography ([@bib0585]). Nsp1 is autocleaved internally at M180-A181 by PCPα to release Nsp1α, and Nsp1β is released from Nsp2 (not shown here) by PCPβ (arrows). PCPα and PCPβ motifs are indicated by black areas. C76 and H46 participate in both PCPα activity and ZF2 formation. Panel (B) represents the authentic structures of the Nsp1α and Nsp1β subunits used in our study ([@bib0585], [@bib0770]). Panel (C) represents the structure of two subunits based on the previous prediction ([@bib0150]), and panel (D) represents the constructs used in the study by [@bib0075]. ZF2 is destroyed in the Nsp1α constructs in (C) and (D) due to the loss of M180.

#### 3.1.2.2. Downregulation of type I IFN by Nsp1 {#sec0095}

##### 3.1.2.2.1. Nsp1 {#sec0100}

The Nsp1 protein of EAV has been reported to localize in the nucleus ([@bib0650]), and recently, PRRSV Nsp1 has also been observed in the nucleus in addition to its cytoplasmic distribution ([Fig. 3](#fig0015){ref-type="fig"}). It is noteworthy that unlike N which contains a distinct NLS motif for its nuclear localization, no known NLS motif is present in either of the Nsp1 cleavage products, suggesting that Nsp1 nuclear localization is not importin-dependent but that an intermediary is involved. The nuclear localization of PRRSV Nsp1 has prompted us to hypothesize that Nsp1 may play an accessory role in the nucleus of PRRSV-infected cells. Recent studies from my laboratory and others show that PRRSV Nsp1 modulates type I IFN response in cultured cells ([@bib0075], [@bib0110], [@bib0280]). Nsp1 appears to block dsRNA-induced IRF3 and IFN promoter activities, but IRF3 phosphorylation and its nuclear translocation occur normally in the presence of Nsp1. Degradation of IRF3 was initially hypothesized as the mechanism for IFN down-regulation by PRRSV. It is striking however, that PRRSV Nsp1 degrades the CREB (cyclic AMP response element binding)-binding protein (CBP) in the nucleus and thus down-regulates the recruitment of CBP by IRF3 in the nucleus ([@bib0280]). For full activation, IRF3 requires phosphorylation and dimerization, and when in the nucleus recruits co-activator CBP/p300, which directs the complex to bind IRF3 responsive elements for transcription initiation ([@bib0755], [@bib0575]). By degrading CBP, Nsp1 seems to block the full activation of IRF3 and subsequently inhibits the assembly of the IFN enhanceosome, leading to the inhibition of IFN production. IRF3 is stable in the presence of Nsp1, and CBP degradation is proteasome-dependent, indicating that CBP degradation is not due to Nsp1 protease activity but that an intermediary is involved. CBP degradation may be induced via polyubiquitinylation.

CBP possesses histone acetyltransferase activity and dissociates histones for chromatin relaxation in the DNA promoter region. The CBP/p300 co-activators function in concert with a variety of transcription factors including c-Myc, p53, STATs, NF-κB, PIAS1, and the IRF family ([@bib0045], [@bib0355], [@bib0375], [@bib0440], [@bib0760], [@bib0785]). Therefore, CBP acts as an important regulator for many cellular processes. Since PRRSV Nsp1 degrades CBP, a question arises whether PRRSV Nsp1 will interfere with general cell transcription activities. The Thogoto virus ML protein, which is a homolog of the influenza virus NS1 protein, inhibits association of IRF3 with CBP and also interacts with RNA polymerase II transcription factor IIB (TFIIB; [@bib0250], [@bib0680]). However, the ML protein--TFIIB interaction has surprisingly little effects on host cell gene expression in general, but shows a strong negative impact on the IRF3-regulated and NF-κB-regulated promoters. Thus, it is conceivable that PRRSV Nsp1-mediated CBP degradation may also be negligible for general cellular transcription but have a more specific and potent role for IRF3-regulated IFN induction. CBP degradation is a novel strategy for viral evasion from the host response, and PRRSV Nsp1 may form a new class of viral antagonists for IFN modulation. For EAV, Nsp1 is interactive with p100, a transcription co-activator that also interacts with regulatory proteins of other viruses ([@bib0640]). The significance of EAV Nsp1 binding to p100 has not yet been explored and remains to be determined.

##### 3.1.2.2.2. Nsp1α and Nsp1β {#sec0105}

Since PRRSV Nsp1 is autocleaved into two subunits, we have sought to determine the role of the individual subunits for IFN regulation. Two constructs were made for Nsp1α and Nsp1β according to the authentic cleavage of Nsp1 and each subunit was FLAG-tagged for detection. It appears that Nsp1α contains potent activity for IFN down-regulation even though Nsp1β also harbors a moderate level of regulatory activity ([@bib0770]). Recent data from my laboratory reveals that Nsp1α has the ability to suppress NF-κB activation when stimulated with dsRNA or TNF-α. Nsp1α substantially suppressed NF-κB activation, and the suppressive activity was RIG-I dependent. Since IFNβ production requires the coordinated activation of transcription factors to result in the formation of a transcription competent enhanceosome, we have also examined whether NF-κB suppression by Nsp1α is associated with the suppression of IFN-β production. Besides IRF3, which binds at PRD I/III, the IFNβ promoter region also contains PRD II for NF-κB binding and PRD IV for AP-1 binding, and thus NF-κB binding for PRD II has specifically been examined. It appears that Nsp1α indeed inhibited the binding of NF-κB to the PRD II region of IFN promoters, and this inhibition resulted from the blocking of NF-κB nuclear translocation from the cytoplasm. The C-terminal extension of fourteen amino acids in the Nsp1α subunit was critical in maintaining the biological activity of Nsp1α for IFN-β and NF-κB, suggesting again that the newly identified ZF2 in Nsp1α may participate in modulating host response. Nsp1α inhibited IκB phosphorylation and as a consequence NF-κB translocation to the nucleus was blocked, and subsequently NF-κB stimulated gene expression was inhibited. Since Nsp1 degrades CBP in the nucleus ([@bib0280]) and blocks NF-κB activation in the cytoplasm, and because Nsp1 is distributed to both the nucleus and cytoplasm of the cell, it is conceivable that the nuclear form of Nsp1α is responsible for CBP degradation in the nucleus and the cytoplasmic form of Nsp1α participates in NF-κB inactivation in the cytoplasm, which both lead to a potent suppression of IFN-β production. Thus PRRSV Nsp1 may be considered a multifunctional protein modulating the IFN surveillance system of the host.

In our study, neither Nsp1α nor Nsp1β blocked the nuclear localization of IRF3 ([@bib0770]), and this finding is contradictory to a previous report ([@bib0075]). Beura reported that IRF3 nuclear localization was inhibited by Nsp1β, and as a consequence, the IFNβ promoter activity was down-regulated in the presence of Nsp1β. In their study however, both Nsp1α and Nsp1β constructs were modified forms from the authentic cleavage products, such that Nsp1α was shorter by 7 residues at the C-terminus and therefore ZF2 was destroyed, while their Nsp1β had 26 additional residues at the N-terminus, when compared to the authentic subunits ([Fig. 2](#fig0010){ref-type="fig"}D). Such unusual features of their constructs may have attributed to the contradictory observations compared to our data. Pestivirus classical swine fever virus (CSFV) and bovine viral diarrhea virus (BVDV) N^pro^ protein down-regulates IFN production via IRF3 degradation ([@bib0310], [@bib0060]). For BVDV, both cytopathic (cp) and non-cytopathic (ncp) biotypes can cause acute infections, but only ncpBVDV establishes a persistent infection in infected bovine fetus, and subsequently causes mucosal disease in the calf. NcpBVDV inhibits IFN-β production through binding of N^pro^ to IRF3 ([@bib0040], [@bib0120]), and N^pro^ also contains a zinc-binding TRASH motif ([@bib0195]). This zinc-finger motif is essential to IRF3 degradation and IFN regulation by BVDV ([@bib0605]). PRRSV Nsp1α contains two zinc finger motifs, ZF1 and ZF2, and a study is in progress using mutant PRRSVs generated from an infectious cDNA clone to examine whether any of these motifs in Nsp1α also regulates CBP degradation, NF-κB suppression, and/or IFN induction. Such studies will warrant the functional contribution of the newly identified zinc-finger structure in Nsp1α to biological significance.

The downregulation of NF-κB by Nsp1α is striking. [@bib0330] previously reported the activation of the NF-κB pathway by PRRSV in MARC-145 cells and suggested the generation of reactive oxygen species (ROS) as the cause for NF-κB activation. This report initially led us to exclude the possibility of NF-κB downregulation by Nsp1. Further studies in my laboratory however found that PRRSV Nsp1 and Nsp1α possessed the ability to downregulate NF-κB in both MARC-145 and HeLa cells. The NF-κB response is generally instant upon stimulation, and NF-κB downregulation by PRRSV Nsp1α is observed within minutes upon stimulation. The previous report by [@bib0330] examined NF-κB activation at one and two days post-infection, and it is possible that the timing of determination may have caused the differences between our results. Various confirmatory experiments are underway.

#### 3.1.2.3. Interaction of Nsp1 with PIAS1 {#sec0110}

By yeast 2-hybrid screening, PRRSV Nsp1 has also been found to interact with the protein inhibitor of activated STAT1 (PIAS1) (unpublished data). PIAS1 is a member of the PIAS protein family known to modulate the activity of many transcription factors including STATs and NF-κB ([@bib0535]). PIAS1 is a negative regulator for STAT1 in the IFN-mediated JAK-STAT pathway and thus regulates the IFN response ([@bib0570], [@bib0130]). The specific binding of PIAS with Nsp1 has been confirmed independently in another laboratory (personal communication, Dr. H.C. Liu, North Carolina State University, Raleigh, NC). This finding supports a previous report that Nsp1 also plays a role in the JAK-STAT IFN signaling pathway ([@bib0110]). In that study, PRRSV Nsp1 was shown to inhibit ISRE (IFN-stimulated regulatory response element) promoter activity and also inhibited STAT1 nuclear translocation. The PIAS1 protein also possesses SUMO (small ubiquitin-like modifier) E3 ligase activity. Many proteins are post-translationally modified by SUMO, known as sumoylation ([@bib0705]). Sumoylation occurs through a unique pathway but analogous to ubiquitinylation during proteosome-dependent protein degradation, and for this process, a SUMO molecule is conjugated to the lysine residue of the target protein within the consensus sequence of ψK×E (ψ represents a hydrophobic amino acid) by E3 ligase. Since PIAS1 may function as an E3 ligase required for ubiquitinylation of a protein, Nsp1 may bring CBP to PIAS1, facilitating the ubiquitinylation of CBP and subsequent degradation. Alternatively, it is possible that the binding of Nsp1 to PIAS1 triggers sumoylation of Nsp1 and facilitates Nsp1 transport to the nucleus.

3.2. Cytoplasmic proteins of PRRSV and their modulatory role for innate immunity {#sec0115}
--------------------------------------------------------------------------------

### 3.2.1. Immune modulation by Nsp11 {#sec0120}

The core enzymes required for PRRSV RNA synthesis include RNA-dependent RNA polymerase (RdRp) and RNA helicase in Nsp9 and Nsp10, respectively, and Nsp11 is a recently discovered additional viral enzyme. Nsp11 contains endoribonuclease activity and is highly conserved in nidoviruses. The domain for this enzyme activity is unique and designated 'NendoU'. A distant relationship has been identified between NendoU and the XendoU family, an endoribonuclease derived from *Xenopus laevis.* For arteriviruses, the NendoU domain is located in the C-terminal region of Nsp11 ([@bib0470]), and for coronaviruses, it is mapped to Nsp15 and contains uridylate-specific cleavage activity of RNA ([@bib0080], [@bib0245]). Coronavirus Nsp15 forms hexamers to achieve optimal enzymatic activity ([@bib0750]). The role of NendoU in viral RNA synthesis has been demonstrated for EAV and SARS-CoV, and partially for PRRSV ([@bib0430]). NendoU is able to process RNA independently from Mn^2+^ with the preference of uridylate using a cleavage mechanism resembling that of RNase A. At least one other viral protein containing RNase activity has been shown to inhibit type I IFN induction. Pestivirus BVDV E^rns^ is a glycoprotein found on the surface of the viral membrane, and the E^rns^ protein contains exoribonuclease activity that targets viral RNA. Cleavage of extracellular viral RNA prevents activation of the RNA-binding receptor TLR3, blocking the dsRNA-mediated signaling pathways ([@bib0380]), and thus BVDV E^rns^ acts as an inhibitor of dsRNA-induced IFN response of cells.

In our laboratory, PRRSV Nsp11 has been examined for its role for IFNβ production ([@bib0580]; unpublished data). In Nsp11 expressing cells, the IFNβ promoter and IRF3 reporter activities were significantly suppressed, and the inhibitory activity was mediated through the RIG-I signaling pathway. The Nsp11-mediated IFN inhibition was triggered by either dsRNA, a constitutively active form of RIG-I and IPS-1, or IRF3 as an inducer. Subsequent experiments showed that PRRSV Nsp11 functions to block IRF3 activation. Nsp11 inhibited IRF3 phosphorylation and thus blocked the nuclear translocation of IRF3 in stimulated cells. It is hypothesized that the NendoU activity of Nsp11 is associated with the inhibition of IRF3 activation. The amino acids at positions H3735, H3750, and H3779 of PP1a/1b are catalytic sites for PRRSV NendoU activity, and mutation of these amino acids to H3735A, H3750A, and H3779A resulted in the loss of IFN inhibitory function of Nsp11.

Since RNA binds to pattern recognition receptors such as PKR, RIG-I/MAD5, TLR-3, and TLR7, and because Nsp11 is an RNase, it is possible that Nsp11 cleaves mRNAs non-specifically leading to suppression of IFN response. We have only examined the IRF3-mediated IFN production pathway, but Nsp11 may also function in other signaling branches in the production pathway and the JAK-STAT signaling pathway. A recent report indicates that PRRSV Nsp11 is able to reduce NF-κB promoter activation ([@bib0075]). Although this report did not specify whether the reduction of NF-κB promoter activity was associated with suppression of type I IFN production or other cellular processes, it is in support of our data that Nsp11 functions in IFN down-regulation. NendoU activity in Nsp11 may have multiple functions in the modulation of host cell response.

We have constructed a series of NendoU mutant PRRSVs such that the association of NendoU activity with IFN response may be determined using infectious viruses ([@bib0580], unpublished data). Of 7 NendoU mutant viruses generated using an infectious clone, catalytic site mutant viruses were non-viable. Mutation of D3786A and D3810A completely blocked viral RNA synthesis and virus production, which is consistent with the previous observation for EAV and coronaviruses ([@bib0245], [@bib0255], [@bib0470]). It is believed that in PRRSV, both D3786 and D3810 play a pivotal role in stabilizing the secondary structure of Nsp11, similar to Nsp15 in SARS-CoV. Thus, mutation of D3786A and D3810A abolishes their NendoU activity and therefore the IFN inhibitory activity. Our results provide first evidence that the NendoU domain of PRRSV Nsp11 plays an important role associated with the modulation of type I IFN induction.

### 3.2.2. Immune modulation by Nsp2 {#sec0125}

Nsp2 is the largest protein in PRRSV. It is highly heterogenous and extensive genetic and antigenic variations exist with deletions and mutations. The highly virulent PRRSV reported in the recent outbreaks in China contains two non-contiguous deletions in the Nsp2 hypervariable region ([@bib0630], [@bib0790]), and these deletions serve as genetic markers for differentiation from other PRRSV. Recent studies suggest the involvement of Nsp2 in host immune modulation. A deletion of 12 amino acids at position 456--469 in the cysteine proteinase (CP) domain of Nsp2 did not result in the production of viable virus. A deletion of 32 amino acids at positions 691--722, designated ES3, downstream of CP rendered a viable virus production and the ES3 mutant virus showed enhanced cytolytic activity and increased growth kinetics. When infected with the ES3 mutant virus, pigs produced a higher viral load and decreased production of IL-1β and TNF-α in PBMCs and macrophages compared with parental virus ([@bib0115]), suggesting that Nsp2 play a role in the modulation of host innate immune response during infection. An independent study ([@bib0210]) shows that the CP of Nsp2 belongs to the ovarian-tumor (OTU) domain deubiquitinases superfamily and may deconjugate ubiquitin (Ub) and ISG15 from cellular proteins thereby inhibiting Ub- and ISG15-dependent innate immune responses. ISG15 is a 15-kDa protein that is able to covalently modify target proteins in much the same way as ubiquitin to induce antiviral state. The addition of ISG15 targets RIG-I and JAK1 and plays an important role in IFN response. A further study shows that the PRRSV Nsp2 OTU domain antagonizes the type I interferon induction by interfering with the NF-κB signaling pathway ([@bib0590]). Inhibition of NF-κB activation is mediated by interfering with the poly-ubiquitination process of IKKα, which subsequently prevents IKKα degradation. The OTU domain in PRRSV Nsp2 acts as broad spectrum deISGylases and deubuquitinases. The dual deconjugating activity provides an additional example that Nsp2 is a multifunctional IFN antagonist. Protease activity by the Nsp2 OTU domain has the capacity to evade cytokine pathways that are important for antiviral immunity. Deletion of the OTU domain from the viral genome generates a nonviable virus.

4. Conclusions {#sec0130}
==============

The immune surveillance system protects host cells from viral infection, and viruses have evolved to escape this system for efficient proliferation in the host. Host cells produce cytokines and chemokines in response to viral infection and among such effector molecules, type I IFNs are principal antiviral cytokines and therefore are effective targets for viruses to disarm host surveillance. Many viruses are known to express proteins that counteract the production of type I IFN. RNA viruses are generally small, and to compensate for their small coding capacity, their proteins are often multifunctional. Ample evidence is available for different evasion strategies for different viruses, and viral proteins function to circumvent the IFN response by interfering with host cell gene expression, blocking the IFN induction cascade, and inhibiting the IFN signaling pathways ([@bib0285], [@bib0480], [@bib0465], [@bib0265], [@bib0610]).

The PRRSV genome is duplicated into dsRNA during replication, which can trigger a cascade of cellular events, and PRRSV has evolved to subvert host IFN surveillance for effective survival. To date, at least four viral proteins involved in the modulation of innate immunity have been studied: N as a structural protein and three non-structural proteins, Nsp1, Nsp2, and Nsp11. Among these, N and Nsp1 are nuclear-cytoplasmic proteins distributed in the both nucleus and cytoplasm of cell. The N protein in the nucleolus appears to participate in the cell cycle progression as well as immune modulation, whereas Nsp1 inhibits IFN production by degrading CREB-binding protein in the nucleus. Specifically, the Nsp1α subunit of Nsp1 blocks phosphorylation of IκB and thus prevents IκB degradation to retain NF-κB in the cytoplasm in the silent form. It is probable that CBP degradation is mediated by Nsp1α in the nucleus while NF-κB activation is blocked by the cytoplasmic form of Nsp1α. While the N protein nuclear localization is NLS-dependent, the basis for Nsp1α nuclear transport is unknown, and the structural differences between the nuclear and cytoplasm forms of Nsp1α are also unknown. It is intriguing that PIAS protein appears to interact with both N protein and Nsp1α subunit, and their biological consequences need to be further studied. Both N and Nsp1α may be sumoylated by PIAS1 to function in cellular processes, or binding of N and Nsp1α to PIAS1 may alter the normal PIAS function to gain benefits for favorable replication of the virus. Nsp2 is a cysteine protease, and deconjugation of ubiquitin and ISG15 by Nsp2 from key signaling molecules is an emerging mechanism of immune evasion by PRRSV to silence the inflammatory and IFN responses. Nsp4 is a serine protease whereas Nsp11 is an endoribonuclease, and both Nsp\'s have also been suggested to participate in the immune evasion strategy of PRRSV. Blocking against PRRSV-induced inhibition of the innate immune response may lead to the future development of effective vaccines or the discovery of novel antiviral compounds. The understanding of viral mechanisms modulating the normal cellular processes during infection will be a key to developing an effective future control strategy for PRRS.
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